Related Experiment Videos

Invasive pulmonary penicilliosis: successful therapy with amphotericin B

M S Gelfand1, F H Cole, R C Baskin

  • 1Deparment of Medicine, Methodist Hospital, Memphis, TN 38104.

Insights

Invasive pulmonary penicilliosis in immunocompromised patients requires thorough investigation. Amphotericin B treatment can be effective, particularly with improved immune function.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Invasive fungal infections pose significant risks to immunocompromised individuals.
  • Penicillium species are increasingly recognized as potential pathogens in clinical settings.
  • Pulmonary involvement by fungi necessitates accurate diagnosis and effective treatment strategies.

Observation:

  • A case of invasive pulmonary penicilliosis was documented in an immunocompromised patient.
  • Diagnosis was confirmed through thoracotomy, allowing for direct tissue sampling and pathological examination.
  • The patient presented with a severe fungal infection affecting the lungs.

Findings:

  • The patient's invasive pulmonary penicilliosis was successfully treated with amphotericin B.
  • Fungal isolates of Penicillium species were identified from the patient's samples.
  • Treatment efficacy was associated with a reversal or moderation of the patient's immunosuppression.

Implications:

  • Penicillium species in normally sterile sites of immunosuppressed patients warrant aggressive investigation.
  • Amphotericin B is a viable therapeutic option for invasive pulmonary penicilliosis.
  • Managing the underlying immunosuppression is crucial for successful antifungal treatment outcomes.

Related Concept Videos